+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibition of stress-induced adrenocorticotropin and prolactin secretion mediating hypophysiotropic factors by antagonist of AMPA type glutamate receptor

Inhibition of stress-induced adrenocorticotropin and prolactin secretion mediating hypophysiotropic factors by antagonist of AMPA type glutamate receptor

Journal of Reproduction and Development 53(3): 545-554

Glutamate is the dominant excitatory neurotransmitter in a large number of physiological processes including neuroendocrine regulation. Some pharmacological studies have shown that different subtypes of glutamate receptor, such as the N-methyl-D-aspartic acid (NMDA) and alpha-amino-3-hydroxy-5-methy-4-isoxazolepropionic acid (AMPA) receptors, are involved in stress-induced adrenocorticotropin (ACTH) and prolactin secretion. However, the roles of the respective glutamate receptors and the mechanism of ACTH and prolactin secretion during stress via these receptors have not been investigated in detail. In the present study, we evaluated the role of AMPA-type glutamate receptor in ACTH and prolactin regulation under restraint stress in adult male rats. Male rats pretreated with a selective AMPA receptor antagonist, 2, 3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX; 50 microg), through a lateral ventricle cannula were stressed by immobilization. Administration of NBQX inhibited ACTH and prolactin secretion in response to restraint stress. However, NBQX had no significant effects on the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis, as measured by the accumulation of 3, 4-dihydroxyphenylalanine (DOPA). In addition, administration of NBQX suppressed stress-induced prolactin secretion in the male rats pretreated with alpha-MT, an inhibitor of dopamine synthesis, and infused with dopamine solution (2.5 microg/200 microl/10 min). These results indicated that the effects of NBQX on prolactin secretion might be mediated by non-dopamine mechanisms. The contents of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) in the median eminence (ME) of the male rats decreased during restraint stress; however, the fluctuations in CRH and AVP were eliminated by NBQX administration. These results suggest that stress-induced ACTH and prolactin release mediated by neurotransmission via AMPA receptors might be partly attributable to hypophysiotropic regulatory factors in the hypothalamus.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 014082934

Download citation: RISBibTeXText

PMID: 17272925

Related references

Selective Inhibition of Magnocellular Vasopressin Neurons by Hypoosmolality: Effect on Histamine- and Stress-Induced Secretion of Adrenocorticotropin and Prolactin. Neuroendocrinology 67(4): 330-335, 1998

Selective inhibition of magnocellular vasopressin neurons by hypoosmolality: effect on histamine- and stress-induced secretion of adrenocorticotropin and prolactin. Neuroendocrinology 67(5): 330-335, 1998

Factors regulating AMPA-type glutamate receptor subunit changes induced by sciatic nerve injury in rats. Journal of Comparative Neurology 426(2): 229-242, October 16, 2000

Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 117(1): 323-329, 1985

Stress-induced secretion of adrenocorticotropin, corticosterone, and prolactin in experimentally and genetically hypertensive rats. Endocrinology 112(2): 580-585, 1983

Regulation of hypophysiotropic factors mediating ACTH secretion. Annals of the New York Academy of Sciences 512: 205-217, 1987

Pharmacologocal profile of e2007, a novel orally active ampa type glutamate receptor antagonist. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 36 18, 2002

Post receptor mechanisms mediating dopaminergic inhibition of prolactin secretion. Biggio, G Et Al (Ed ) Symposia in Neuroscience, Vol 3 Modulation Of Central And Peripheral Transmitter Function; 4th Capo Boi Conference, Villasimius, Italy, June 2-7, 1985 Xii+624p Liviana Press: Padova, Italy (Dist By Springer-Verlag: New York, N Y , Usa; Berlin, West Germany) Illus 359-366, 1986

Simultaneous Blockade of Two Glutamate Receptor Subtypes (Nmda and Ampa) Results in Stressor-Specific Inhibition of Prolactin and Corticotropin Release. Neuroendocrinology 69(5): 316-323, 1999

Simultaneous blockade of two glutamate receptor subtypes (NMDA and AMPA) results in stressor-specific inhibition of prolactin and corticotropin release. Neuroendocrinology 69(5): 316-323, 1999

Developmental shift in adrenergic receptor type mediating catecholamine effects on stress-induced ACTH secretion in the rat. Society for Neuroscience Abstracts 21(1-3): 1628, 1995

The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry 36(1): 27-31, 2003

Failure of reserpine to block ether induced release of prolactin physiological evidence that stress induced prolactin release is not caused by acute inhibition of prolactin inhibiting factor secretion. Life Sciences Part I Physiology & Pharmacology 12(7): 327-335, 1973

Non-peptidic corticotropin-releasing hormone receptor type 1 antagonist reverses restraint stress-induced shortening of sodium pentobarbital-induced sleeping time of rats: evidence that an increase in arousal induced by stress is mediated through CRH receptor type 1. Neuroscience Letters 255(2): 103-106, 1998

AMPA/kainate-type glutamate receptor antagonist reduces progressive inner hair cell loss after transient cochlear ischemia. Brain Research 979(1-2): 194-202, 25 July, 2003